Shaneda Warren Andersen1, Amy Trentham-Dietz2, Ronald E Gangnon3, John M Hampton4, Halcyon G Skinner3, Corinne D Engelman3, Barbara E Klein5, Linda J Titus6, Kathleen M Egan7, Polly A Newcomb8. 1. University of Wisconsin, Carbone Cancer Center, Madison, WI 53726, USA; Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA. Electronic address: snandersen@uwalumni.com. 2. University of Wisconsin, Carbone Cancer Center, Madison, WI 53726, USA; Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA. 3. Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA. 4. University of Wisconsin, Carbone Cancer Center, Madison, WI 53726, USA. 5. Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA. 6. Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03756, USA. 7. Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA. 8. University of Wisconsin, Carbone Cancer Center, Madison, WI 53726, USA; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Abstract
BACKGROUND: Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) associated with breast cancer risk. Some of these loci have unknown functional significance and may mediate the effects of hormonal exposures on breast cancer risk. We examined relationships between breast cancer susceptibility variants and menstrual/reproductive factors using data from two population-based studies. METHODS: The first analysis was based on a sample of 1328 women age 20-74 who participated as controls in a case-control study of breast cancer conducted in three U.S. states. We evaluated the associations between age at menarche, age at natural menopause and the reproductive lifespan with 13 previously identified breast cancer variants. Associations were also examined with a genetic score created as the sum of at-risk alleles across the 13 variants. For validation, significant results were evaluated in a second dataset comprised 1353 women age 43-86 recruited as part of a cohort study in Wisconsin. RESULTS: Neither the genetic score nor any of the 13 variants considered individually were associated with age at menarche or reproductive lifespan. Two SNPs were associated with age at natural menopause; every increase in the minor allele (A) of rs17468277 (CASP8) was associated with a 1.12 year decrease in menopause age (p=0.02). The minor allele (G) of rs10941679 (5p12) was associated with a 1.01 year increase in age at natural menopause (p=0.01). The results were not replicated in the validation cohort (B=-0.61, p=0.14 and B=-0.01, p=.0.98, respectively). CONCLUSIONS: The evaluated variants and reproductive experiences may work through separate pathways to influence breast cancer risk.
BACKGROUND: Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) associated with breast cancer risk. Some of these loci have unknown functional significance and may mediate the effects of hormonal exposures on breast cancer risk. We examined relationships between breast cancer susceptibility variants and menstrual/reproductive factors using data from two population-based studies. METHODS: The first analysis was based on a sample of 1328 women age 20-74 who participated as controls in a case-control study of breast cancer conducted in three U.S. states. We evaluated the associations between age at menarche, age at natural menopause and the reproductive lifespan with 13 previously identified breast cancer variants. Associations were also examined with a genetic score created as the sum of at-risk alleles across the 13 variants. For validation, significant results were evaluated in a second dataset comprised 1353 women age 43-86 recruited as part of a cohort study in Wisconsin. RESULTS: Neither the genetic score nor any of the 13 variants considered individually were associated with age at menarche or reproductive lifespan. Two SNPs were associated with age at natural menopause; every increase in the minor allele (A) of rs17468277 (CASP8) was associated with a 1.12 year decrease in menopause age (p=0.02). The minor allele (G) of rs10941679 (5p12) was associated with a 1.01 year increase in age at natural menopause (p=0.01). The results were not replicated in the validation cohort (B=-0.61, p=0.14 and B=-0.01, p=.0.98, respectively). CONCLUSIONS: The evaluated variants and reproductive experiences may work through separate pathways to influence breast cancer risk.
Authors: Montserrat García-Closas; Kathleen M Egan; Polly A Newcomb; Louise A Brinton; Linda Titus-Ernstoff; Stephen Chanock; Robert Welch; Jolanta Lissowska; Beata Peplonska; Neonila Szeszenia-Dabrowska; Witold Zatonski; Alicja Bardin-Mikolajczak; Jeffery P Struewing Journal: Hum Genet Date: 2006-02-17 Impact factor: 4.132
Authors: M García-Closas; K M Egan; J Abruzzo; P A Newcomb; L Titus-Ernstoff; T Franklin; P K Bender; J C Beck; L Le Marchand; A Lum; M Alavanja; R B Hayes; J Rutter; K Buetow; L A Brinton; N Rothman Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-06 Impact factor: 4.254
Authors: Brian L Sprague; Amy Trentham-Dietz; Montserrat Garcia-Closas; Polly A Newcomb; Linda Titus-Ernstoff; John M Hampton; Stephen J Chanock; Jonathan L Haines; Kathleen M Egan Journal: Carcinogenesis Date: 2007-04-21 Impact factor: 4.944
Authors: Stefan Nickels; Thérèse Truong; Rebecca Hein; Kristen Stevens; Katharina Buck; Sabine Behrens; Ursula Eilber; Martina Schmidt; Lothar Häberle; Alina Vrieling; Mia Gaudet; Jonine Figueroa; Nils Schoof; Amanda B Spurdle; Anja Rudolph; Peter A Fasching; John L Hopper; Enes Makalic; Daniel F Schmidt; Melissa C Southey; Matthias W Beckmann; Arif B Ekici; Olivia Fletcher; Lorna Gibson; Isabel dos Santos Silva; Julian Peto; Manjeet K Humphreys; Jean Wang; Emilie Cordina-Duverger; Florence Menegaux; Børge G Nordestgaard; Stig E Bojesen; Charlotte Lanng; Hoda Anton-Culver; Argyrios Ziogas; Leslie Bernstein; Christina A Clarke; Hermann Brenner; Heiko Müller; Volker Arndt; Christa Stegmaier; Hiltrud Brauch; Thomas Brüning; Volker Harth; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Diether Lambrechts; Dominiek Smeets; Patrick Neven; Robert Paridaens; Dieter Flesch-Janys; Nadia Obi; Shan Wang-Gohrke; Fergus J Couch; Janet E Olson; Celine M Vachon; Graham G Giles; Gianluca Severi; Laura Baglietto; Kenneth Offit; Esther M John; Alexander Miron; Irene L Andrulis; Julia A Knight; Gord Glendon; Anna Marie Mulligan; Stephen J Chanock; Jolanta Lissowska; Jianjun Liu; Angela Cox; Helen Cramp; Dan Connley; Sabapathy Balasubramanian; Alison M Dunning; Mitul Shah; Amy Trentham-Dietz; Polly Newcomb; Linda Titus; Kathleen Egan; Elizabeth K Cahoon; Preetha Rajaraman; Alice J Sigurdson; Michele M Doody; Pascal Guénel; Paul D P Pharoah; Marjanka K Schmidt; Per Hall; Doug F Easton; Montserrat Garcia-Closas; Roger L Milne; Jenny Chang-Claude Journal: PLoS Genet Date: 2013-03-27 Impact factor: 5.917
Authors: Montserrat Garcia-Closas; Per Hall; Heli Nevanlinna; Karen Pooley; Jonathan Morrison; Douglas A Richesson; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Jose I Arias; Roger L Milne; Gloria Ribas; Anna González-Neira; Javier Benítez; Pilar Zamora; Hiltrud Brauch; Christina Justenhoven; Ute Hamann; Yon-Dschun Ko; Thomas Bruening; Susanne Haas; Thilo Dörk; Peter Schürmann; Peter Hillemanns; Natalia Bogdanova; Michael Bremer; Johann Hinrich Karstens; Rainer Fagerholm; Kirsimari Aaltonen; Kristiina Aittomäki; Karl von Smitten; Carl Blomqvist; Arto Mannermaa; Matti Uusitupa; Matti Eskelinen; Maria Tengström; Veli-Matti Kosma; Vesa Kataja; Georgia Chenevix-Trench; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Peter Devilee; Christi J van Asperen; Catharina E Jacobi; Rob A E M Tollenaar; Petra E A Huijts; Jan G M Klijn; Jenny Chang-Claude; Silke Kropp; Tracy Slanger; Dieter Flesch-Janys; Elke Mutschelknauss; Ramona Salazar; Shan Wang-Gohrke; Fergus Couch; Ellen L Goode; Janet E Olson; Celine Vachon; Zachary S Fredericksen; Graham G Giles; Laura Baglietto; Gianluca Severi; John L Hopper; Dallas R English; Melissa C Southey; Christopher A Haiman; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Daniel O Stram; David J Hunter; Susan E Hankinson; David G Cox; Rulla Tamimi; Peter Kraft; Mark E Sherman; Stephen J Chanock; Jolanta Lissowska; Louise A Brinton; Beata Peplonska; Jan G M Klijn; Maartje J Hooning; Han Meijers-Heijboer; J Margriet Collee; Ans van den Ouweland; Andre G Uitterlinden; Jianjun Liu; Low Yen Lin; Li Yuqing; Keith Humphreys; Kamila Czene; Angela Cox; Sabapathy P Balasubramanian; Simon S Cross; Malcolm W R Reed; Fiona Blows; Kristy Driver; Alison Dunning; Jonathan Tyrer; Bruce A J Ponder; Suleeporn Sangrajrang; Paul Brennan; James McKay; Fabrice Odefrey; Valerie Gabrieau; Alice Sigurdson; Michele Doody; Jeffrey P Struewing; Bruce Alexander; Douglas F Easton; Paul D Pharoah Journal: PLoS Genet Date: 2008-04-25 Impact factor: 5.917
Authors: Chloé Sarnowski; Maryam Kavousi; Steve Isaacs; Ellen W Demerath; Linda Broer; Taulant Muka; Oscar H Franco; Mohammad Arfan Ikram; André Uitterlinden; Nora Franceschini; Kathryn L Lunetta; Joanne M Murabito Journal: Menopause Date: 2018-04 Impact factor: 2.953
Authors: Laura Fejerman; Mariana C Stern; Esther M John; Gabriela Torres-Mejía; Lisa M Hines; Roger K Wolff; Kathy B Baumgartner; Anna R Giuliano; Elad Ziv; Eliseo J Pérez-Stable; Martha L Slattery Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-09-12 Impact factor: 4.254